Costa FO, et al., 2013 [37] |
Brazil |
Case-control |
45 (22–71) |
Both |
any tooth loss |
Based on blood sugar |
238 |
|
|
5.1 (1.13–9.30) |
Deborah L. et al., 2013 [38] |
USA |
Cross-sectional |
74.02 (0.05) |
Both |
any tooth loss |
Self-report |
379,021 |
|
1.68 (1.55–1.82) |
1.25 (1.13–1.37) |
Sensorn, W. et al., 2012 [17] |
Thailand |
Cross-sectional |
50.5 (20–86) |
Both |
any tooth loss |
Based on blood sugar |
605 |
|
1.72 (1.03–2.73) |
|
Kapp, J. M. et al., 2007 |
Columbia |
Cross-sectional |
18–99 |
Both |
any tooth loss |
Self-report |
155,280 |
|
1.64 (1.49–1.80) |
1.11 (0.99–1.24) |
Yoo, et al. 2019 [15] |
South Korea |
Cohort |
> 18 |
Both |
any tooth loss |
Based on blood sugar |
10,215 |
sex, age, and place of residence, social and economic factors |
1.29 (1.23–1.36) |
1.34 (1.26–1.43) |
Dar-Odeh, et al. 2019 [39] |
Saudi Arabia. |
Cross-sectional |
31.2 (10.13) |
Women |
any tooth loss |
Self-report |
1768 |
|
1.04 (1.02–1.07) |
|
Frias-Bulhosa, et al. 2018 [28] |
Portugal |
Case-control |
63.8 (12.8) |
Both |
any tooth loss |
Self-report |
666 |
|
1.65 (0.88–3.14) |
|
Hastings, et al. 2017 [7] |
USA |
Cross-sectional |
55.8 (3.5) |
Male |
any tooth loss |
Self-report |
275 |
adjusted for same variables as Model 2 plus dental insurance, arthritis, hypertension, and number of medications. |
1.43 (0.87–2.38) |
|
Rai, et al. 2019 [40] |
USA |
Cross-sectional |
55.5 (16.01) |
Both |
at least tooth loss > = 5 |
Self-report |
1338 |
CVD, Tobacco use, Age, Gender, Hispanic |
1.7 (1.20–2.30) |
1.2 (0.80–1.22) |
Simila, et al. 2018 [41] |
Finland |
Cross-sectional |
> 46 |
Women |
any tooth loss |
Based on blood sugar |
5950 |
|
3.4 (1.79–6.44) |
2.99 (1.54–5.8) |
Joshipura, et al. 2018 [42] |
USA |
Cohort |
50.4 (6.8) |
Both |
at least tooth loss > = 5 |
Based on blood sugar |
1206 |
|
1.48 (0.76–2.89) |
|
Shamala, et al. 2017 [27] |
Yemen |
Case-control |
> 30 |
Both |
at least tooth loss > = 5 |
Self-report |
272 |
|
4 (2–8.1) |
|
Oluwagbemigun, et al. 2015 [26] |
Germany |
Cohort |
51.8 (8.22) |
Both |
any tooth loss |
Self-report |
24,313 |
Age, Sex, BMI, education, occupation, smoking, alcohol consumption, physical activity, use of vitamin and/or mineral supplements, antibiotics, hormone |
|
1.08 (0.81–1.44) |
Delgado-Pérez, et al. 2017 [29] |
Mexico |
Cross-sectional |
50.7 (16.2) |
Both |
any tooth loss |
|
60 |
replacement therapy (women) and non–steroidal anti–inflammatory drugs |
3.42 (2.32–5.04) |
3.13 (2.09–4.69) |
Buysschaert, et al. 2017 [30] |
Belgium |
Cross-sectional |
62 (15) |
Both |
at least tooth loss > = 5 |
Based on blood sugar |
160 |
|
1.72 (0.85–3.54) |
|
Liljestrand, et al. 2015 [43] |
Finland |
Cohort |
60.8 (8.44) |
Both |
at least tooth loss > = 5 |
Self-report |
7629 |
|
1.37 (1.02–1.86) |
|
Kowall, et al. 2015 [44] |
Germany |
Cross-sectional |
57.3 (10.82) |
Both |
any tooth loss |
Based on blood sugar |
3086 |
age, sex, BMI, education, smoking, alcohol consumption, total cholesterol, HDL, cholesterol, and triglycerides |
4.02 (3.01–5.36) |
1.05 (0.73–1.49) |
Greenblatt, et al. 2016 [20] |
USA |
Cohort |
18–74 |
Both |
at least tooth loss > = 5 |
Based on blood sugar |
15,113 |
age, Hispanic background, study site/center, nativity status, income, and education, number of dental visits and current health insurance status, alternative healthy eating index, cigarette smoking, and obesity, chronic periodontitis |
2.69 (2.45–2.97) |
1.18 (0.94–1.49) |
De Medeiros, et al. 2021 [45] |
Brazil |
Cross-sectional |
> = 30 |
Both |
any tooth loss |
Based on blood sugar |
60,271 |
Adults |
|
1.11 (1.08–1.14) |
Zhang, et al. 2021 [46] |
USA |
Cohort |
> = 30 |
Both |
any tooth loss |
Based on blood sugar |
5569 |
Adults |
|
2.11 (1.46–3.04) |
Del Carmen, et al. 2021 [47] |
Mexico |
Cross-sectional |
41.6 (15.4) |
Both |
any tooth loss |
Based on blood sugar |
1640 |
Community Oral Health Program |
3.62 (2.86–4.57) |
|
Laouali, et al. 2021 [48] |
France |
Cross-sectional |
70.17 (6.22) |
Women |
any tooth loss |
Self-report |
2857 |
French national health insurance |
|
1.07 (0.97–1.19) |